Fizyhealth
Olympia Pharmacy tirzepatide pricing

Does Olympia Pharmacy still offer compounded tirzepatide?

No. Olympia Pharmacy no longer compounds tirzepatide. The FDA resolved the Zepbound/Mounjaro shortage in December 2024, which removed the legal basis for 503A and 503B compounding of essentially a copy of tirzepatide. Olympia was one of seven large 503B outsourcing facilities nationally producing compounded tirzepatide during the shortage era. As of June 2026, tirzepatide is not available from Olympia Pharmacy. Clinics evaluating Olympia for tirzepatide pricing will need to explore alternative sourcing options.

This page explains the regulatory change that ended tirzepatide compounding at Olympia Pharmacy, what Olympia currently offers for weight management, and how to evaluate the remaining options.

Compare Fizy Health vs Olympia Pharmacy

Proudly Partnered With

Why Olympia Pharmacy stopped compounding tirzepatide

Olympia Pharmaceuticals — Olympia's FDA-registered 503B outsourcing arm — was among the largest producers of compounded tirzepatide in the US during the shortage era. According to FDA outsourcing facility product reports, it was one of seven large 503B facilities nationally producing compounded tirzepatide when the FDA declared the Zepbound shortage over in December 2024. The FDA established phased enforcement deadlines, compounder industry groups filed federal lawsuits and sought preliminary injunctions, but courts denied those injunctions and enforcement deadlines held. As of mid-2025, routine compounding of essentially a copy of tirzepatide is not legally permissible for 503A or 503B entities. Olympia Pharmacy's active weight-management offering is now compounded liraglutide, launched June 2025 under the FDA shortage exception that still applies to that molecule.

What Olympia Pharmacy offers for weight management in 2026

Olympia's current compounded GLP-1 option is liraglutide, a GLP-1 receptor agonist marketed as Saxenda (weight management) and Victoza (diabetes). Liraglutide remains on the FDA drug shortage list as of June 2026, making compounding legally permissible under current regulations. Olympia launched it in two formulations in June 2025. Unlike tirzepatide — a dual GIP/GLP-1 receptor agonist taken weekly — liraglutide requires daily injections and carries a different patient adherence and vial-consumption profile. For clinics that previously built programs around compounded tirzepatide's once-weekly injection convenience, the transition to daily liraglutide represents a material change in patient experience and economics.

Pricing for compounded liraglutide follows Olympia Pharmacy's standard quote-driven model: no published per-vial rates on olympiapharmacy.com, custom clinical-liaison quotes, and volume-negotiated terms. Because daily dosing means more injections per month, per-dose cost and supply economics differ fundamentally from weekly tirzepatide programs. Ask Olympia Pharmacy for written per-dose cost across the liraglutide titration ladder — 0.6, 1.2, 1.8, 2.4, and 3.0 mg — so your patient pricing and margin math are built on realistic consumption rates.

Evaluating alternatives when tirzepatide is off the table

Clinics that built programs around compounded tirzepatide are now navigating a narrow regulatory window. Narrow exceptions still exist — documented excipient allergies or doses not commercially available — but routine patient-specific compounding that amounts to essentially a copy of an approved product is off-limits for both 503A and 503B entities. Before committing to a new GLP-1 protocol or pharmacy, confirm the current legal status with a pharmacy compliance team or legal counsel familiar with FDA drug compounding enforcement.

Fizy Health shows per-vial 503A cost on each medication in its catalog before checkout, including weight-management SKUs available through its assigned LegitScript-certified 503A partners. If your clinic is evaluating what to use after compounded tirzepatide, compare per-dose landed cost on available options in a visible catalog against any quote you receive from Olympia Pharmacy on liraglutide. Make the comparison on per-dose delivered cost — not per-vial rate — because daily and weekly injection frequencies produce very different monthly economics.

Evaluate Olympia liraglutide — or use a multi-partner pass-through model?

Olympia Pharmacy fits if

Olympia Pharmacy

Daily liraglutide from a 503A/503B network fits your program.

  • Your weight-management program is transitioning to or already built around daily compounded liraglutide.
  • You want 503B office-use batch supply and the DrScript portal workflow.
  • Your patient population adapts to daily injection protocols and you can confirm rates via clinical liaison.
Consider Fizy Health if

Fizy Health

You want visible cost across available weight-management options before you order.

  • You need to compare available weight-management SKUs across multiple 503A partners in one session.
  • You want per-vial 503A cost visible before checkout to quote patients and protect margin.
  • You batch hormone, peptide, and weight-management refills and want one cart, not multiple portal logins.
If you choose Fizy Health

What your weight-management program gets when cost is visible.

Olympia Pharmacy weight-management pricing arrives after a quote. These are the outcomes when per-vial cost is on the screen before you order.

See all features
Keep evaluating Olympia Pharmacy pricing

More on Olympia Pharmacy GLP-1 and weight-management cost.

See the full Olympia Pharmacy pricing guide
FAQ

What clinics ask about Olympia Pharmacy and tirzepatide.

  • Availability

    Does Olympia Pharmacy still compound tirzepatide?

    No. Olympia Pharmacy no longer compounds tirzepatide. The FDA resolved the Zepbound/Mounjaro shortage in December 2024 and established enforcement deadlines. Courts upheld those deadlines, ending routine 503A and 503B compounding of essentially a copy of tirzepatide by mid-2025.

  • History

    Did Olympia Pharmacy compound tirzepatide before the shortage ended?

    Yes. According to FDA outsourcing facility product reports, Olympia Pharmaceuticals (Olympia's 503B arm) was one of seven large facilities nationally producing compounded tirzepatide during the shortage era, before the FDA resolved the Zepbound shortage in December 2024.

  • Current offering

    What GLP-1 does Olympia Pharmacy compound now?

    As of June 2026, Olympia Pharmacy's primary compounded GLP-1 offering is liraglutide — launched June 2025. Liraglutide is still on the FDA shortage list, making it legally compoundable. It requires daily injections, unlike weekly tirzepatide.

  • Dosing

    How different is daily liraglutide from weekly tirzepatide economically?

    Significantly different. Daily dosing means more injections per month and faster vial consumption. Per-dose cost and total monthly supply cost should be recalculated for liraglutide across its titration ladder (0.6 to 3.0 mg daily) rather than extrapolated from weekly tirzepatide economics.

  • Comparison

    How is Fizy Health different for clinics post-tirzepatide compounding?

    Fizy Health shows resolved per-vial 503A cost on available weight-management options before checkout, with a disclosed facilitation fee. You can compare options across assigned 503A partners without a separate clinical-liaison process for each source.

  • Exceptions

    Are there any exceptions that allow tirzepatide compounding?

    Narrow exceptions exist — for example, documented patient excipient allergies or a dose not commercially available. Routine patient-specific compounding that amounts to a copy of an approved product is off-limits for both 503A and 503B entities. Confirm current legal status with pharmacy compliance counsel before ordering.

Sources reviewed June 2026

  • Olympia Pharmacy public website and medication directory (olympiapharmacy.com), reviewed June 2026.
  • FDA Drug Shortage Database and enforcement communications regarding tirzepatide and semaglutide compounding, reviewed June 2026.
  • FDA Outsourcing Facility Product Reports (public, 2024), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Evaluate weight-management options on visible per-vial cost.

Compare landed cost on available weight-management SKUs, batch refills in one cart, and decide with real numbers. Free to start.

Start Ordering FreeFizy Health vs Olympia Pharmacy